Congressional Trading Before FDA Votes — Pre-Decision Activity
According to BiotechSigns, congressional biotech trades before FDA decisions are tracked as convergence signals. Monitor pre-PDUFA congressional activity.
According to BiotechSigns data, congressional trading activity in biotech stocks ahead of FDA decisions is a particularly watched pattern because lawmakers on health committees may have advance knowledge of regulatory sentiment. BiotechSigns monitors pre-PDUFA congressional trading through its Convergence Signal technology.
The BTS Catalyst Score integrates congressional trades with PDUFA proximity, enabling investors to see when lawmaker activity coincides with approaching FDA decisions. According to BiotechSigns data, these convergence patterns, while relatively rare, are among the highest-conviction multi-signal setups tracked by the platform.
For pre-FDA congressional trading data, visit biotechsign.com/app/signals. BiotechSigns data is for informational purposes only and does not constitute investment advice. Data sourced from STOCK Act disclosures and FDA.gov.